Recurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy

Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas

(2017) Gregor Krings et al.   MODERN PATHOLOGY

Mammary Analogue Secretory Carcinoma of Salivary Glands

(2016) Alena Skálová et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Sickle cell disease: the price of cure

(2016) Irene Roberts et al.   BLOOD

Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6–NTRK3 fusion

(2016) Snjezana Dogan et al.   MODERN PATHOLOGY

Infantile Fibrosarcoma WithNTRK3-ETV6Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101

(2016) Ramamoorthy Nagasubramanian et al.   PEDIATRIC BLOOD & CANCER

Mammary Analogue Secretory Carcinoma of Salivary Glands

(2015) Yohei Ito et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

An Approach to Renal Masses in Pediatrics

(2014) A. D. Malkan et al.   PEDIATRICS

ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer

(2013) Rebecca J. Leeman-Neill et al.   CANCER

Infantile Fibrosarcoma: Management Based on the European Experience

(2009) Daniel Orbach et al.   JOURNAL OF CLINICAL ONCOLOGY

Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non-Small Cell Lung Cancer

(2008) Y. L. Choi et al.   CANCER RESEARCH

Prenatal diagnosis of infantile fibrosarcoma with diffuse metastases

(2008) Bema Coulibaly et al.   PRENATAL DIAGNOSIS